Atlas Trials

Evaluate the Efficacy and Safety of FB704A in Adult With Severe Asthma

Clinical trial NCT05018299 · COMPLETED

Trial details

NCT number
NCT05018299
Sponsor
Oneness Biotech Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Severe Asthma
Start date
2021-09-30
Primary completion
2026-05-08
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.